We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current CLGN market cap is 55.49M. The company's latest EPS is USD -0.6129 and P/E is -7.90.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 433k | 10.18M | 43k | 299k | 98k |
| Operating Income | -3.52M | 5.68M | -4.6M | -5.07M | -4.33M |
| Net Income | -3.72M | 5.76M | -4.38M | -4.69M | -4.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.32M | 6.14M | 15.64M | 299k | 10.96M |
| Operating Income | -7.63M | -5.6M | 65k | -17.1M | -7.51M |
| Net Income | -11.16M | -5.77M | 237k | -16.93M | -7.02M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 35.76M | 41.57M | 37.56M | 34.13M | 30.29M |
| Total Liabilities | 5.87M | 5.53M | 5.16M | 5.79M | 5.85M |
| Total Equity | 29.89M | 36.04M | 32.4M | 28.34M | 24.45M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.75M | 10.84M | 51.22M | 37.77M | 34.13M |
| Total Liabilities | 6.66M | 6.36M | 6.1M | 5.49M | 5.79M |
| Total Equity | 4.09M | 4.48M | 45.12M | 32.28M | 28.34M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.45M | -7.19M | -418k | -2.76M | -3.25M |
| Investing | -145k | -541k | -784k | -1.16M | -82k |
| Financing | 803k | 892k | 1.11M | 1.11M | 9k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.7M | -4.45M | 2.5M | -13.7M | -2.76M |
| Investing | -1.46M | -519k | -31.56M | 28.92M | -1.16M |
| Financing | 5.41M | 4.47M | 38.76M | 1.87M | 1.11M |
| Market Cap | 55.49M |
| Price to Earnings Ratio | -7.90 |
| Price to Sales Ratio | 5.06 |
| Price to Cash Ratio | 2.08 |
| Price to Book Ratio | 1.96 |
| Dividend Yield | - |
| Shares Outstanding | 11.45M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 3.24 (42.13%) |
| Company Name | CollPlant Biotechnologies Ltd |
| Address |
4 oppenheimer rehovot, center 7670104 |
| Website | https://www.collplant.com |
| Industry | real estate (6500) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
